{
    "clinical_study": {
        "@rank": "40283", 
        "arm_group": [
            {
                "arm_group_label": "Behavioral Activation Therapy", 
                "arm_group_type": "Experimental", 
                "description": "Behavioral Activation (BA) Treatment will be delivered in eight, 30 minute individual sessions over an 8-week period. BA treatment will focus on encouraging subjects to participate in activities that they find enjoyable and rewarding. In addition, this arm will receive standard smoking cessation therapy, nicotine patch, and either nicotine gum or nicotine lozenge."
            }, 
            {
                "arm_group_label": "Health and Smoking Education", 
                "arm_group_type": "Active Comparator", 
                "description": "Health and Smoking Education (HSE) Treatment will be delivered in eight, 30 minute individual sessions over an 8-week period. HSE treatment will focus on smoking, health, and the impact of smoking on the subject's health. In addition, this arm will receive standard smoking cessation therapy, nicotine patch, and either nicotine gum or nicotine lozenge."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine whether behavioral activation as an adjuvant to\n      standard smoking cessation treatment improves smoking cessation outcomes among veterans with\n      PTSD relative to a comparably intense combination of standard smoking cessation treatment +\n      health and smoking education. It is expected that behavioral activation will produce more\n      successful results than health and smoking education when paired with standard smoking\n      cessation treatment."
        }, 
        "brief_title": "Behavioral Activation for Smoking Cessation in Veterans With PTSD", 
        "completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Tobacco Dependence", 
            "PTSD"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Stress Disorders, Post-Traumatic", 
                "Tobacco Use Disorder"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to examine whether behavioral activation as an adjuvant to\n      standard smoking cessation treatment improves smoking cessation outcomes among veterans with\n      PTSD relative to a comparably intense combination of standard smoking cessation treatment +\n      health and smoking education. It is expected that behavioral activation will produce more\n      successful results than health and smoking education when paired with standard smoking\n      cessation treatment.\n\n      After an initial phone screen, in-person screening, and baseline assessment, enrolled\n      participants will be randomized to either behavioral activation therapy and standard smoking\n      cessation treatment (BA+ST) or health and smoking education and standard smoking cessation\n      treatment (HSE+ST). Both groups will meet with a therapist once a week for 8 weeks to\n      receive either BA+ST or HSE+ST. Participants' mood and smoking outcomes will be monitored\n      throughout the 8 weeks of treatment and at 2 follow-up visits and 2 follow-up phone calls."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Report smoking an average of 10 or more cigarettes daily for at least six months\n\n          -  Report a desire to quit smoking\n\n          -  Meet criteria for current PTSD\n\n          -  Speak and read English\n\n          -  Agree to participate in the study\n\n          -  Be   18 years old\n\n          -  Be a veteran\n\n        Exclusion Criteria:\n\n          -  Meeting criteria for psychotic or bipolar disorder\n\n          -  Psychoactive substance abuse or dependence (excluding nicotine dependence) within the\n             past 6 months\n\n          -  Inability to give informed, voluntary, written consent to participate\n\n          -  Current use of any pharmacotherapy for smoking cessation not provided by the\n             researchers during the quit  attempt\n\n          -  Use of non-cigarette tobacco products as a primary form of tobacco use\n\n          -  Being currently suicidal or homicidal\n\n          -  Being medically unable to use the nicotine patch or nicotine gum/lozenge\n\n          -  Psychotropic medication changes within 3 months of study initiation and during active\n             treatment\n\n          -  Current engagement in evidence-based therapies for PTSD or depression\n\n          -  Pregnant or trying to become pregnant\n\n          -  Incarceration"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01995123", 
            "org_study_id": "MHBA-002-12F"
        }, 
        "intervention": [
            {
                "arm_group_label": "Behavioral Activation Therapy", 
                "description": "Behavioral Activation (BA) Treatment will be delivered in eight, 30 minute individual sessions over an 8-week period. BA treatment will focus on encouraging subjects to participate in activities that they find enjoyable and rewarding.", 
                "intervention_name": "Behavioral Activation Therapy", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Health and Smoking Education", 
                "description": "Health and Smoking Education (HSE) Treatment will be delivered in eight, 30 minute individual sessions over an 8-week period. HSE treatment will focus on smoking, health, and the impact of smoking on the subject's health.", 
                "intervention_name": "Health and Smoking Education", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Behavioral Activation Therapy", 
                    "Health and Smoking Education"
                ], 
                "description": "Standard smoking cessation therapy will be delivered in eight, 20-minute individual sessions over an 8-week period.", 
                "intervention_name": "Standard Smoking Cessation Therapy", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Tobacco dependence", 
            "PTSD", 
            "Behavioral Activation Therapy"
        ], 
        "lastchanged_date": "May 28, 2014", 
        "location": {
            "contact": {
                "email": "marvin.rupp@va.gov", 
                "last_name": "Marvin G Rupp", 
                "phone": "608-280-7007"
            }, 
            "contact_backup": {
                "email": "Nasia.Safdar@va.gov", 
                "last_name": "Nasia Safdar, MD PhD", 
                "phone": "(608) 280-7007"
            }, 
            "facility": {
                "address": {
                    "city": "Madison", 
                    "country": "United States", 
                    "state": "Wisconsin", 
                    "zip": "53705"
                }, 
                "name": "William S. Middleton Memorial Veterans Hospital, Madison, WI"
            }, 
            "investigator": {
                "last_name": "Jessica Cook, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Behavioral Activation for Smoking Cessation in Veterans With PTSD", 
        "overall_contact": {
            "email": "Nasia.Safdar@va.gov", 
            "last_name": "Nasia Safdar, MD PhD", 
            "phone": "(608) 280-7007"
        }, 
        "overall_contact_backup": {
            "email": "marvin.rupp@va.gov", 
            "last_name": "Marvin G Rupp", 
            "phone": "(608) 280-7007"
        }, 
        "overall_official": {
            "affiliation": "William S. Middleton Memorial Veterans Hospital, Madison, WI", 
            "last_name": "Jessica Cook, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "7-day point prevalence abstinence at 26-weeks postquit (measured via single end-point analysis and via abstinence over time).", 
            "measure": "Abstinence from tobacco", 
            "safety_issue": "No", 
            "time_frame": "26 weeks post target quit date"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01995123"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Time to first relapse after target quit date", 
                "measure": "Time to tobacco relapse", 
                "safety_issue": "No", 
                "time_frame": "26 weeks post target quit date"
            }, 
            {
                "description": "PTSD symptoms as assessed via the Clinician-Administered PTSD Scale (CAPS).", 
                "measure": "PTSD symptoms", 
                "safety_issue": "No", 
                "time_frame": "5 weeks post target quit date (end of treatment)"
            }
        ], 
        "source": "Department of Veterans Affairs", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Wisconsin, Madison", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}